NFKB1 and anemia (phenotype): The administration of ASP improved iron availability, abrogated the suppression of erythropoiesis by inflammatory cytokines, and effectively reversed anemia via inhibiting inflammatory hepcidin and NF-κB activation in ACD rats (Figure 7).